Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "Digital PCR Market - A Global and Regional Analysis: Focus on Type, ...

Oncology Focus : CAR-T and CAR-NK therapies represent ~30% of all cell and gene trials, with a strong focus on solid and hematological malignancies. Significant attention on gastrointestinal tract and ...

Begin your TipRanks Premium journey today. Oncolytics Biotech (ONCY) Company Description: Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid ...

Maxim Group analyst Jason McCarthy maintained a Buy rating on Oncolytics Biotech (ONCY – Research Report) yesterday and set a price ...

Type 2 Diabetes, In Vivo Model, High-Voltage Electrotherapy, Glucose Tolerance Test (GTT), Hematological Analysis Kriman, V. (2024) Study of the Effect of High-Voltage Low-Frequency Electrotherapy on ...

Johnson & Johnson (NYSE: JNJ) today announced results from additional analyses of the Phase 2 DAHLIAS study highlighting improvement in key measures of disease activity and significant IgG reduction ...

CAR T cell therapy has revolutionized cancer treatment, achieving significant success in hematological cancers through ...

Our clinical studies program is focused on advancing our trial and hematological malignancies and supporting continuing publication and presentation of data. The programs are being led by key sites ...

Our growing volume of in vitro and in vivo data support the potential to deliver broadly effective and safe cancer therapies that can overcome the shortcomings of currently marketed therapeutics by ...